NDC 72162-1378 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Amphetamine Sulfate 2.5 mg/1; Amphetamine Aspartate Monohydrate 2.5 mg/1; Dextroamphetamine Sulfate 2.5 mg/1; Dextroamphetamine Saccharate 2.5 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC72162-1378

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Bryant Ranch Prepack
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA205401
Marketed since
March 16, 2020
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
72162-1378-1100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1378-1)Apr 3, 2026

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products